Clinical Trials Browser

Phase 1 × Urinary Bladder Neoplasms × Doxorubicin × Clear all

NCT00479128 2025-10-28

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

Phase 1 Active not recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00003133 2013-06-28

Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer

Phase 1 Completed

Urinary Bladder Neoplasms